- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.09. | CHMP backs Novo's haemophilia A drug Frehemgo | ||
| 18.09. | MPs seek probe into UK-US pharma deal's impact on NHS | ||
| 18.09. | Ultragenyx gets FDA nod for first Sanfilippo A gene therapy | ||
| 18.09. | Which biotechs have raised new VC financing this week? | ||
| 17.09. | Bavarian Nordic has found its new CEO | ||
| 17.09. | Bayer's Kerendia gets broader use in diabetic kidney disease | ||
| 17.09. | Boehringer launches hub for patient experience data | ||
| 17.09. | NICE finally backs Enhertu for HER2-low breast cancer | ||
| 17.09. | Novo taps Anthropic's Claude AI for drug discovery | ||
| 16.09. | Wales takes UK lead on needle-free anaphylaxis prevention | ||
| 16.09. | Legend Biotech names ex-Novartis exec as CEO | ||
| 16.09. | TikTok parent ByteDance raises cash for drug AI spinout Anew | ||
| 16.09. | AI spots drugs that may be repurposed for priority pathogen | ||
| 16.09. | FDA unveils framework for its expedited IND pilot | ||
| 16.09. | FDA backs Curium's Bexlutry as 1st 'radioligand equivalent' | ||
| 15.09. | Electra Therapeutics sets terms for IPO, hoping to raise up to $347m | ||
| 15.09. | GSK wagers $750m on Chimagen multiple myeloma therapy | ||
| 15.09. | Chiesi fills permanent CEO role with Flagship's Khougazian | ||
| 15.09. | FDA to decide on Takeda's psoriasis blockbuster hope in Q1 | ||
| 15.09. | WCLC: Lung cancer news from BioNTech, Akeso, and Roche | ||
| 14.09. | GSK showcases positive data with lung cancer drugs at WCLC | ||
| 14.09. | AZ's Etcamah falls short in first-line breast cancer trial | ||
| 14.09. | Scholar Rock gets first drug approval as FDA okays Isembyld | ||
| 14.09. | Resistance grows to Recordati's private equity takeover | ||
| 14.09. | Novo Nordisk rebrands as Novo as new CEO charts turnaround |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.